search
Back to results

Flossing With Chlorhexidine

Primary Purpose

Gingivitis

Status
Completed
Phase
Phase 3
Locations
Canada
Study Type
Interventional
Intervention
Chlorhexidine is the generic name of the mouthwash, Peridex is the brand name.
Sponsored by
University of British Columbia
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gingivitis focused on measuring gingivitis, chlorhexidine, dental floss, RCT, bleeding on probing, gingival and plaque indices

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

To be considered for inclusion into the study, subjects must fulfill the following conditions:

  • 18 years and older
  • Have gingivitis (i.e., have pocket depths of 4 mm or less), but not periodontitis
  • Willing to floss every day and have the necessary dexterity to floss
  • Have a minimum of 20 natural teeth, including 4 molars
  • Have at least 10 bleeding sites
  • Be a non-smoker

Exclusion Criteria:

Subjects will be excluded from the study, if they have any of the following conditions:

  • Pregnant or plan to be pregnant within the next 3 months
  • Allergic to chlorhexidine or quinine sulphate
  • Require pre-medication with antibiotics for dental treatment
  • Currently taking antibiotics
  • Currently taking Dilantin, Cyclosporin A, Nifedipine or other calcium channel blockers, aspirin or anti-coagulants
  • Currently using chlorhexidine or whitening products
  • Have active carious lesions
  • Have orthodontic braces
  • Have more than 2 crowns or bridges
  • Have more than 2 implants
  • Have full or partial dentures
  • Have periodontitis, i.e., pocket depths of 5 mm or more in more than 2 sites in the mouth

Sites / Locations

  • Dr. Ian Low

Outcomes

Primary Outcome Measures

To determine if dental floss presoaked in 0.12% chlorhexidine is more effective at reducing the signs of gingivitis, such as bleeding, than a dental floss in placebo solution of 0.1% quinine sulphate.

Secondary Outcome Measures

Full Information

First Posted
May 8, 2007
Last Updated
August 13, 2008
Sponsor
University of British Columbia
Collaborators
Canadian Foundation for Dental Hygiene Research and Education, British Columbia Dental Hygienists' Association (BCDHA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00471783
Brief Title
Flossing With Chlorhexidine
Official Title
The Effects of Flossing With a Chlorhexidine Solution on Interproximal Gingivitis: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2008
Overall Recruitment Status
Completed
Study Start Date
April 2006 (undefined)
Primary Completion Date
December 2006 (Actual)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of British Columbia
Collaborators
Canadian Foundation for Dental Hygiene Research and Education, British Columbia Dental Hygienists' Association (BCDHA)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To determine if flossing with a dental floss presoaked in chlorhexidine, an anti-microbial mouth wash, would improve the clinical signs of gingivitis, an inflammation of the gums characterized by red, swollen, bleeding gums. And to determine if applying chlorhexidine via dental floss would result in tooth staining, which is common with chlorhexidine mouthwashes.
Detailed Description
Purpose of study: To determine if dental floss presoaked in 0.12% chlorhexidine is more effective at reducing the signs of gingivitis, such as bleeding, than a dental floss in placebo solution of 0.1% quinine sulphate. Trial design: The study will consist of a double-blinded, placebo-controlled parallel three-month clinical trial. Randomization of subjects into study groups: Subjects randomized with a computer-generated randomization table and balanced block design to make the two groups equal in number of subjects. Trial schedule: Screening for potential subjects & consent obtained. Calibration of examiner. Week -1: Professional prophylaxis consisting of scaling and polishing. Week 0: Baseline data (GI, SI, PI, BOP, PD) collected on subjects enrolled into the study. OHI - flossing. Subject randomized into a study group. Week 6: Subjects reassessed for GI, SI, PI, BOP, PD. Compliance check. Replenish floss supply. Subject concerns or questions addressed. Week 12: Subjects reassessed for GI, SI, PI, BOP, PD. All floss boxes and logbook returned. Subject concerns or questions addressed. Subject exited from study and returned to the care of his or her regular dental professional. Measurements for data collection (done in this order): Gingival index (GI) (modification of Löe & Silness, 1963) Stain Index (SI) Plaque index (PI) (modification of Silness and Löe, 1964) Bleeding on Probing (BOP) Probing Depth (PD)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gingivitis
Keywords
gingivitis, chlorhexidine, dental floss, RCT, bleeding on probing, gingival and plaque indices

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
66 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Chlorhexidine is the generic name of the mouthwash, Peridex is the brand name.
Primary Outcome Measure Information:
Title
To determine if dental floss presoaked in 0.12% chlorhexidine is more effective at reducing the signs of gingivitis, such as bleeding, than a dental floss in placebo solution of 0.1% quinine sulphate.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: To be considered for inclusion into the study, subjects must fulfill the following conditions: 18 years and older Have gingivitis (i.e., have pocket depths of 4 mm or less), but not periodontitis Willing to floss every day and have the necessary dexterity to floss Have a minimum of 20 natural teeth, including 4 molars Have at least 10 bleeding sites Be a non-smoker Exclusion Criteria: Subjects will be excluded from the study, if they have any of the following conditions: Pregnant or plan to be pregnant within the next 3 months Allergic to chlorhexidine or quinine sulphate Require pre-medication with antibiotics for dental treatment Currently taking antibiotics Currently taking Dilantin, Cyclosporin A, Nifedipine or other calcium channel blockers, aspirin or anti-coagulants Currently using chlorhexidine or whitening products Have active carious lesions Have orthodontic braces Have more than 2 crowns or bridges Have more than 2 implants Have full or partial dentures Have periodontitis, i.e., pocket depths of 5 mm or more in more than 2 sites in the mouth
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Donald Brunette, Ph.D
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dr. Ian Low
City
2031 West 41st Avenue, Vancouver
State/Province
British Columbia
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Flossing With Chlorhexidine

We'll reach out to this number within 24 hrs